Texas 2019 86th Regular

Texas House Bill HB1338 Introduced / Bill

Filed 02/04/2019

                    86R8966 JSC-D
 By: Pacheco H.B. No. 1338


 A BILL TO BE ENTITLED
 AN ACT
 relating to prescribing low-THC cannabis to certain patients for
 compassionate use.
 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
 SECTION 1.  Section 169.001(2), Occupations Code, is amended
 to read as follows:
 (2)  "Epilepsy" has the meaning assigned by Section
 40.001, Health and Safety Code ["Intractable epilepsy" means a
 seizure disorder in which the patient's seizures have been treated
 by two or more appropriately chosen and maximally titrated
 antiepileptic drugs that have failed to control the seizures].
 SECTION 2.  Section 169.002(b), Occupations Code, is amended
 to read as follows:
 (b)  A physician is qualified to prescribe low-THC cannabis
 to a patient with [intractable] epilepsy if the physician:
 (1)  is licensed under this subtitle;
 (2)  dedicates a significant portion of clinical
 practice to the evaluation and treatment of epilepsy; and
 (3)  is certified:
 (A)  by the American Board of Psychiatry and
 Neurology in:
 (i)  epilepsy; or
 (ii)  neurology or neurology with special
 qualification in child neurology and is otherwise qualified for the
 examination for certification in epilepsy; or
 (B)  in neurophysiology by:
 (i)  the American Board of Psychiatry and
 Neurology; or
 (ii)  the American Board of Clinical
 Neurophysiology.
 SECTION 3.  Section 169.003, Occupations Code, is amended to
 read as follows:
 Sec. 169.003.  PRESCRIPTION OF LOW-THC CANNABIS.  A
 physician described by Section 169.002 may prescribe low-THC
 cannabis to alleviate a patient's seizures if:
 (1)  the patient is a permanent resident of the state;
 (2)  the physician complies with the registration
 requirements of Section 169.004; and
 (3)  the physician certifies to the department that:
 (A)  the patient is diagnosed with [intractable]
 epilepsy;
 (B)  the physician determines the risk of the
 medical use of low-THC cannabis by the patient is reasonable in
 light of the potential benefit for the patient; and
 (C)  a second physician qualified to prescribe
 low-THC cannabis under Section 169.002 has concurred with the
 determination under Paragraph (B), and the second physician's
 concurrence is recorded in the patient's medical record.
 SECTION 4.  This Act takes effect September 1, 2019.